Daniel Nomura

Daniel Nomura

Private Equity Investor bij
The Column Group LLC
Health Technology
Consumer Services
Finance

Profiel

Daniel K.
Nomura
was the founder of Frontier Medicines Corp., founded in 2018, where the title held was Chemistry Professor.
Dr. Nomura was the founder of Vicinitas Therapeutics, Inc., founded in 2022, where the title held was Director.
Current jobs include serving on the Scientific Advisory Board at The University of Texas M.D.
Anderson Cancer Center, The Mark Foundation for Cancer Research (U.S.) Ltd., Oerth Bio LLC, Apertor Pharmaceuticals, Inc., Photys Therapeutics, Inc., and Ecto Therapeutics.
Additionally, Dr. Nomura is an Advisory Partner at a16z Capital Management LLC since 2023 and holds a position at The Column Group LLC starting in 2023.

Actieve functies van Daniel Nomura

BedrijvenFunctieBegin
Private Equity Investor 01-08-2023
Private Equity Investor 01-03-2023
Consultant / Adviseur -
Consultant / Adviseur -
Consultant / Adviseur -
Consultant / Adviseur -
Consultant / Adviseur -

Eerdere bekende functies van Daniel Nomura

BedrijvenFunctieEinde
Oprichter -
Oprichter -
Ervaring van Daniel Nomura in detail bekijken

Opleiding van Daniel Nomura

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

98

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Consumer Services

Consumer Services

Finance

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Beurs
  2. Insiders
  3. Daniel Nomura